Citigroup’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-145,800
| Closed | -$12.4M | – | 7804 |
|
|
2020
Q3 | $12.4M | Buy |
145,800
+7,800
| +6% | +$394K | 0.01% | 1207 |
|
|
2020
Q2 | $4.89M | Buy |
138,000
+51,300
| +59% | +$1.5M | ﹤0.01% | 1879 |
|
|
2020
Q1 | $1.17M | Sell |
86,700
-41,800
| -33% | -$703K | ﹤0.01% | 3007 |
|
|
2019
Q4 | $2.72M | Buy |
128,500
+32,700
| +34% | +$577K | ﹤0.01% | 2664 |
|
|
2019
Q3 | $1.27M | Buy |
95,800
+8,200
| +9% | +$121K | ﹤0.01% | 3367 |
|
|
2019
Q2 | $1.22M | Buy |
87,600
+11,900
| +16% | +$179K | ﹤0.01% | 3403 |
|
|
2019
Q1 | $1.45M | Buy |
75,700
+12,400
| +20% | +$200K | ﹤0.01% | 2997 |
|
|
2018
Q4 | $903K | Buy |
63,300
+5,300
| +9% | +$105K | ﹤0.01% | 3506 |
|
|
2018
Q3 | $1.21M | Sell |
58,000
-2,800
| -5% | -$66.3K | ﹤0.01% | 3277 |
|
|
2018
Q2 | $1.44M | Buy |
60,800
+32,800
| +117% | +$659K | ﹤0.01% | 2995 |
|
|
2018
Q1 | $409K | Sell |
28,000
-154,200
| -85% | -$2.52M | ﹤0.01% | 4208 |
|
|
2017
Q4 | $2.94M | Buy |
182,200
+15,200
| +9% | +$179K | ﹤0.01% | 2304 |
|
|
2017
Q3 | $2.33M | Sell |
167,000
-6,400
| -4% | -$63.8K | ﹤0.01% | 2494 |
|
|
2017
Q2 | $1.53M | Buy |
173,400
+79,600
| +85% | +$559K | ﹤0.01% | 2857 |
|
|
2017
Q1 | $607K | Sell |
93,800
-118,400
| -56% | -$600K | ﹤0.01% | 3700 |
|
|
2016
Q4 | $779K | Buy |
212,200
+202,400
| +2,065% | +$599K | ﹤0.01% | 3941 |
|
|
2016
Q3 | $32K | Buy |
9,800
+1,200
| +14% | +$3.36K | ﹤0.01% | 5948 |
|
|
2016
Q2 | $20K | Sell |
8,600
-18,700
| -68% | -$62.5K | ﹤0.01% | 6175 |
|
|
2016
Q1 | $68K | Buy |
27,300
+26,800
| +5,360% | +$60.3K | ﹤0.01% | 5933 |
|
|
2015
Q4 | $2K | Sell |
500
-10,900
| -96% | -$30.4K | ﹤0.01% | 7309 |
|
|
2015
Q3 | $20K | Buy |
11,400
+3,000
| +36% | +$7.66K | ﹤0.01% | 6045 |
|
|
2015
Q2 | $34K | Buy |
+8,400
| New | +$34.3K | ﹤0.01% | 5791 |
|
Citigroup's IMMU Position: Q4 2020 in Review
Citigroup sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 568,440 shares — an estimated $48.3M sold.
Citigroup first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $48.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Citigroup reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Citigroup sold 568,440 Immunomedics Inc shares in Q4 2020, an estimated $48.3M.
- Citigroup first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Citigroup's Immunomedics Inc position peaked at $48.3M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Citigroup's 13F filing for Q4 2020, filed 11 Feb 2021.